| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 2,021,906 | $5,014,326 | $2.48 | 19 Sep 2025 | By Bios Fund III QP, LP | ||
| Common Stock | 1,424,014 | $3,531,554 | $2.48 | 19 Sep 2025 | By Bios Memory SPV I, LP | ||
| Common Stock | 500,095 | $1,240,235 | $2.48 | 19 Sep 2025 | By Bios Clinical Opportunity Fund, LP | ||
| Common Stock | 418,926 | $1,038,936 | $2.48 | 19 Sep 2025 | By Bios Fund I, LP | ||
| Common Stock | 385,248 | $955,415 | $2.48 | 19 Sep 2025 | By Bios Memory SPV II, LP | ||
| Common Stock | 326,733 | $810,297 | $2.48 | 19 Sep 2025 | By Bios Fund III NT, LP | ||
| Common Stock | 309,748 | $768,175 | $2.48 | 19 Sep 2025 | By Bios Fund III, LP | ||
| Common Stock | 255,765 | $634,297 | $2.48 | 19 Sep 2025 | By Bios Fund II QP, LP | ||
| Common Stock | 245,029 | $607,671 | $2.48 | 19 Sep 2025 | By Bios Fund I QP, LP | ||
| Common Stock | 78,298 | $194,179 | $2.48 | 19 Sep 2025 | By Bios Fund II, LP | ||
| Common Stock | 34,238 | $84,910 | $2.48 | 19 Sep 2025 | By Bios Fund II NT, LP | ||
| Common Stock | 56,229 | $47,232 | $0.8400 | 19 Sep 2025 | Direct | ||
| Stock Option (right to buy) | 0 | 19 Sep 2025 | Direct | Common Stock |
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|